Elevated Levels of Both Cardiomyocyte Membrane and Myofibril Damage Markers Predict Adverse Outcomes in Patients With Chronic Heart Failure

Department of Cardiology and Clinical Laboratory, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan.
Circulation Journal (Impact Factor: 3.94). 05/2008; 72(4):569-74. DOI: 10.1253/circj.72.569
Source: PubMed


Recent studies have shown the presence of ongoing myocardial damage in patients with chronic heart failure (CHF) detected by myofibril and membrane damage markers, cardiac troponin T (TnT) and heart-type fatty acid-binding protein (H-FABP), which identifies patients at increased risk of a future cardiac event (CE: death or rehospitalization because of worsening CHF). There is a difference between TnT and H-FABP in their release kinetics following myocardial damage.
TnT and H-FABP were measured in 103 patients with CHF and in 31 controls. Patients were classified into 4 groups based on detectable (>or=0.01 ng/ml) or undetectable TnT (TnT+ or TnT-) and H-FABP >or= or <4.5 ng/ml (mean + 2 standard deviations in controls) (high-H-FABP or low-H-FABP). Kaplan-Meier analysis showed that the CE-free rate (n=43) was significantly lower in patients with TnT+ and high-H-FABP than in patients in the other 3 groups (patients with TnT+ and low-H-FABP, TnT- and high-H-FABP, and TnT- and low-H-FABP; p=0.02, p=0.001 and p=0.0002, respectively). In stepwise multivariate Cox proportional hazard analysis, TnT+ (p=0.01) and high-H-FABP (p=0.04) were independent predictors of future CE.
Elevated levels of both TnT and H-FABP predict adverse outcomes in CHF patients.

2 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The study explores the relationship between an organization's strategic management process and its use of information and communication technologies. Effective strategic management especially under conditions of changing markets, competition, technology and other environmental factors, appears to rely upon insights from experts. The use of information technologies, the fundamental tools for the information age, could be expected to augment the access to experts and their insights and information and thereby enhance strategic decision making and strategy implementation. The purpose of the study is to identify the characteristics of the information technologies which are used during the various phases of the strategic management process and to determine the sufficiency of the information technologies in meeting the needs of strategic management activities. The development of a technology-strategic management model illustrates the manner in which information technologies currently support the activities which comprise strategic management. The model enables the researcher to highlight the characteristics about the information technologies and about the strategic management activities which they support
    Engineering and Technology Management, 1996. IEMC 96. Proceedings., International Conference on; 09/1996
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Muscle homeostasis involves de novo myogenesis, as observed in conditions of acute or chronic muscle damage. Tumor Necrosis Factor (TNF) triggers skeletal muscle wasting in several pathological conditions and inhibits muscle regeneration. We show that intramuscular treatment with the myogenic factor Arg(8)-vasopressin (AVP) enhanced skeletal muscle regeneration and rescued the inhibitory effects of TNF on muscle regeneration. The functional analysis of regenerating muscle performance following TNF or AVP treatments revealed that these factors exerted opposite effects on muscle function. Principal component analysis showed that TNF and AVP mainly affect muscle tetanic force and fatigue. Importantly, AVP counteracted the effects of TNF on muscle function when delivered in combination with the latter. Muscle regeneration is, at least in part, regulated by caspase activation, and AVP abrogated TNF-dependent caspase activation. The contrasting effects of AVP and TNF in vivo are recapitulated in myogenic cell cultures, which express both PW1, a caspase activator, and Hsp70, a caspase inhibitor. We identified PW1 as a potential Hsp70 partner by screening for proteins interacting with PW1. Hsp70 and PW1 co-immunoprecipitated and co-localized in muscle cells. In vivo Hsp70 protein level was upregulated by AVP, and Hsp70 overexpression counteracted the TNF block of muscle regeneration. Our results show that AVP counteracts the effects of TNF through cross-talk at the Hsp70 level. Therefore, muscle regeneration, both in the absence and in the presence of cytokines may be enhanced by increasing Hsp70 expression.
    PLoS ONE 02/2009; 4(5):e5570. DOI:10.1371/journal.pone.0005570 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycogen synthase kinase-3β (GSK-3β) is a multifunctional Ser/Thr kinase that plays important roles in necrosis and apoptosis of cardiomyocytes. A major mechanism of cell necrosis is the opening of the mitochondrial permeability transition pore (mPTP), which consists of multiple protein subunits, including adenine nucleotide translocase (ANT). The threshold for mPTP opening is elevated by phosphorylation of GSK-3β at Ser9, which reduces activity of this kinase. How inactivation of GSK-3β suppresses mPTP opening has not been fully understood, but evidence to date suggests that preservation of hexokinase-il in the mPTP complex, inhibition of cyclophilin-D-ANT binding, inhibition of p53 and inhibition of ANT into the mitochondria are contributory. GSK-3β phosphorylation is a step to which multiple protective signaling pathways converge, and thus GSK-β phosphorylation is crucial in cardioprotection of a variety of interventions against ischemia/reperfusion injury. Apoptosis of cardiomyocytes by pressure overload or ischemia/reperfusion is also suppressed by inactivation of GSK-3β, in which reduced phosphorylation of p53, heat shock factor-i and myeloid cell leukemia sequence-1 and inhibition of Bax translocation might be involved. Considering predominant roles of GSK-3β in cardiomyocyte death, manipulation of this protein kinase is a promising strategy for myocardial protection in coronary artery disease and heart failure.
    Circulation Journal 07/2009; 73(7):1184-1192. DOI:10.1253/circj.CJ-09-0284 · 3.94 Impact Factor
Show more